hrs4r
Quiero donar
Lupu R, Menendez JA

Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7, 483-493 dx.doi.org/10.2174/138920106779116928
Vilalta-Franch J, Garre-Olmo J, López-Pousa S, Turon-Estrada A, Lozano-Gallego M, Hernàndez-Ferràndiz M, Pericot-Nierga I, Feijóo-Lorza R

Comparison of different clinical diagnostic criteria for depression in Alzheimer disease.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14, 589-597 dx.doi.org/10.1097/01.JGP.0000209396.15788.9d
Fernández-Real JM, Straczkowski M, Vendrell J, Soriguer F, Pérez Del Pulgar S, Gallart L, López-Bermejo A, Kowalska I, Manco M, Cardona F, García-Gil MM, Mingrone G, Richart C, Ricart W, Zorzano A

Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin

Diabetologia, 2006, 49, 2402-2411 dx.doi.org/10.1007/s00125-006-0381-6
Aspa, J, Rajas, O, de Castro, FR, Huertas, MC, Borderías, L, Cabello, FJ, Tábara, J, Hernández-Flix, S, Martinez-Sanchis, A, Torres, A

Impact of initial antibiotic choice on mortality from pneumococcal pneumonia

EUROPEAN RESPIRATORY JOURNAL, 2006, 27, 1010-1019 dx.doi.org/10.1183/09031936.06.00126004
Pérez-Rodon J, Aboal J, Morales M, Masià R

Enfermedad de Kawasaki con afección coronaria en el adulto.

REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59, 1203-1204
Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, Vivancos J, Castillo J, Lizasoain I, Moro MA, Dávalos A

A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke.

JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203, 711-717 dx.doi.org/10.1084/jem.20051979
Menendez JA, Vellon L, Lupu R

DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 18, 1081-1087
Scornik FS, Desai M, Brugada R, Guerchicoff A, Pollevick GD, Antzelevitch C, Pérez GJ

Functional expression of "cardiac-type" Nav1.5 sodium channel in canine intracardiac ganglia.

Heart Rhythm, 2006, 3, 842-850 dx.doi.org/10.1016/j.hrthm.2006.03.021
López-Pousa S, Olmo JG, Franch JV, Estrada AT, Cors OS, Nierga IP, Gelada-Batlle E

Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil or galantamine.

AGE AND AGEING, 2006, 35, 365-371 dx.doi.org/10.1093/ageing/afj083
Fernández-Real JM, Vendrell J, Ricart W

Circulating adiponectin and plasma fatty acid profile

CLINICAL CHEMISTRY, 2005, 51, 603-609 dx.doi.org/10.1373/clinchem.2004.041350
Serena J, Blanco M, Castellanos M, Silva Y, Vivancos J, Moro MA, Leira R, Lizasoain I, Castillo J, Dávalos A

The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.

Stroke, 2005, 36, 1921-1926 dx.doi.org/10.1161/01.STR.0000177870.14967.94
Fiessinger, JN, Huisman, MV, Davidson, BL, Bounameaux, H, Francis, CW, Eriksson, H, Lundström, T, Berkowitz, SD, Nyström, P, Thorsén, M, Ginsberg, JS

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis -: A randomized trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293, 681-689 dx.doi.org/10.1001/jama.293.6.681
Vendrell J, Broch M, Fernandez-Real JM, Gutiérrez C, Simón I, Megia A, Gallart L, Ricart W, Richart C

Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study

DIABETIC MEDICINE, 2005, 22, 387-392 dx.doi.org/10.1111/j.1464-5491.2004.01392.x
Brugada R, Hong K, Cordeiro JM, Dumaine R

Short QT syndrome.

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173, 1349-1354 dx.doi.org/10.1503/cmaj.050596
Menendez JA, Vellon L, Oza BP, Lupu R

Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.

JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 94, 857-863 dx.doi.org/10.1002/jcb.20367
Recasens M, López-Bermejo A, Ricart W, Vendrell J, Casamitjana R, Fernández-Real JM

An inflammation score is better associated with basal than stimulated surrogate indexes of insulin resistance

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90, 112-116 dx.doi.org/10.1210/jc.2004-0708
Patarroyo ME, Alba MP, Vargas LE, Silva Y, Rosas J, Rodríguez R

Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register.

BIOCHEMISTRY, 2005, 44, 6745-6754 dx.doi.org/10.1021/bi050214z
Biarnés J, Fernández-Real JM, Fernández-Castañer M, del Mar García M, Soler J, Ricart W

Differential regulation of insulin action and tumor necrosis factor a system activity by metformin

METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54, 235-239 dx.doi.org/10.1016/j.metabol.2004.08.018
Maury P, Hollington L, Duparc A, Brugada R

Short QT syndrome: Should we push the frontier forward?

Heart Rhythm, 2005, 2, 1135-1137 dx.doi.org/10.1016/j.hrthm.2005.06.023
Silva Y, Puigdemont M, Castellanos M, Serena J, Suñer RM, García MM, Dávalos A

Semi-intensive monitoring in acute stroke and long-term outcome.

CEREBROVASCULAR DISEASES, 2005, 19, 23-30 dx.doi.org/10.1159/000081908

Conoce el IDIBGI!

menu